Natamycin’s Distinct FDA Approvals
Natamycin, also known as pimaricin, is a polyene macrolide antibiotic produced by the bacterium Streptomyces natalensis. Its potent antifungal properties have made it valuable in two very different fields, each requiring a separate approval process from the U.S. Food and Drug Administration (FDA). The FDA regulates medications for therapeutic use differently than food additives, leading to natamycin's dual status.
Medical Use: The Drug Approval Process
As a prescription medication, natamycin is marketed under the brand name Natacyn® and is available as a 5% ophthalmic suspension for topical application to the eyes. This particular formulation was approved by the FDA in 1978. It is the only FDA-approved topical antifungal eye drop on the market and is considered the gold standard for treating specific fungal eye infections.
The approval for Natacyn is based on its proven safety and effectiveness in treating several fungal conditions affecting the outer eye. This includes:
- Fungal blepharitis: Inflammation of the eyelid.
- Fungal conjunctivitis: Inflammation of the conjunctiva, the membrane lining the eyelid and eye surface.
- Fungal keratitis: An infection of the cornea, which can be particularly severe, especially when caused by organisms like Fusarium solani.
When applied as eye drops, natamycin works by binding to sterols in the fungal cell membrane, disrupting its function and ultimately killing the fungal cells. The drug has poor systemic absorption, meaning it does not get into the bloodstream in significant amounts when used topically, which is an important safety consideration for its FDA approval.
Food Additive Use: GRAS Status and Specific Applications
Natamycin also has extensive approval for use as a natural food preservative, designated with the E number E235. The FDA permits its direct addition to food intended for human consumption under 21 CFR 172.155, specifically for inhibiting mold and yeast growth on certain products. The FDA has also accepted a “Generally Recognized As Safe” (GRAS) notification for specific uses, such as in yogurt.
Its function in food science is to extend shelf life and prevent spoilage by targeting molds and yeasts without affecting the bacterial cultures crucial for fermented products like cheese. Applications in the US include:
- Cheese: Approved as an antimycotic, with a limit of 20 milligrams per kilogram (20 ppm) in the finished product. It is applied to the surface of cheese, either in powdered form or via a spray/dip.
- Yogurt: The FDA issued a “no questions” letter regarding its GRAS status for use as an antimycotic in yogurt at levels not exceeding 5 ppm.
- Other Dairy: Use has been extended to non-standard identity cottage cheese, sour cream, and cream cheese.
- Baked Goods: Permitted on the surface of some breads and in soft tortillas.
Comparing FDA-Approved Uses
Feature | Medical Use (Natacyn®) | Food Additive Use (E235) |
---|---|---|
Regulatory Body | FDA's Center for Drug Evaluation and Research (CDER) | FDA's Center for Food Safety and Applied Nutrition (CFSAN) |
Purpose | To treat existing fungal infections of the eye. | To prevent spoilage by inhibiting mold and yeast growth. |
Administration | Topical ophthalmic application (eye drops). | Applied to the surface via dipping, spraying, or direct addition. |
Dosage Form | 5% ophthalmic suspension. | Crystalline powder or liquid solution. |
Regulatory Status | Approved New Drug Application (NDA). | Permitted as a direct food additive under 21 CFR 172.155 and has GRAS status for some uses. |
Requires Prescription | Yes, it is a prescription-only drug. | No, it is used in food manufacturing. |
The Importance of Context in FDA Approval
The differing FDA approval pathways for natamycin highlight how regulatory bodies assess a substance based on its intended application. What is safe and effective as a topical eye drop is evaluated differently than a preservative added to food. Key differences include the route of administration, the required dosage, and the potential for systemic absorption. The FDA’s rigorous standards ensure that the appropriate safety and efficacy profile is established for each specific use. Concerns over antimicrobial resistance from food applications were addressed during the review process, noting natamycin's poor absorption and that low-level food use poses minimal risk to medical applications.
Conclusion
In summary, the question "Is natamycin FDA approved?" has a nuanced answer: Yes, it is, but for very specific and distinct applications. Natamycin is FDA-approved as the topical ophthalmic drug Natacyn®, used to treat fungal eye infections. Separately, it is approved as a food additive (E235) and has GRAS status for use in certain dairy products to prevent mold and yeast growth. This dual regulatory status reflects its versatility as an antifungal agent, with strict regulations in place to ensure safety for both pharmaceutical and food applications. Both approvals underscore the substance's efficacy and safety when used according to its defined purpose.
Learn more about natamycin's regulatory status on the FDA website.